as part of complex therapy for acute hypoxic conditions (acute cerebral hypoxia, ischemic stroke, transient ischemic attack). The drug is prescribed in the acute, subacute and recovery periods of cerebrovascular accidents
with discirculatory encephalopathy and various traumatic and toxic brain lesions, in the recovery period after surgery
with primary and secondary carnitine deficiency, including in patients with chronic renal failure on hemodialysis
with cardiomyopathy, ischemic heart disease (angina pectoris, acute myocardial infarction, postinfarction conditions), hypoperfusion due to cardiogenic shock and other metabolic disorders in the myocardium
Contraindications
There are contraindications, consult with a specialist before use
Используя сайт, вы предоставляете согласие на обработку ваших персональных данных с помощью сервисов веб-аналитики. Чтобы ознакомиться с нашими Положениями о конфиденциальности и об использовании
файлов cookie, нажмите здесь.